| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |